EP1235521A2 - Terminolaterale anastomosesysteme - Google Patents

Terminolaterale anastomosesysteme

Info

Publication number
EP1235521A2
EP1235521A2 EP00992636A EP00992636A EP1235521A2 EP 1235521 A2 EP1235521 A2 EP 1235521A2 EP 00992636 A EP00992636 A EP 00992636A EP 00992636 A EP00992636 A EP 00992636A EP 1235521 A2 EP1235521 A2 EP 1235521A2
Authority
EP
European Patent Office
Prior art keywords
fitting
petal
host vessel
base
support device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00992636A
Other languages
English (en)
French (fr)
Inventor
James G. Whayne
Russell A. Houser
Sidney D. Fleischman
Patrick M. Owens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Converge Medical Inc
Original Assignee
Converge Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Converge Medical Inc filed Critical Converge Medical Inc
Publication of EP1235521A2 publication Critical patent/EP1235521A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/064Blood vessels with special features to facilitate anastomotic coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/32053Punch like cutting instruments, e.g. using a cylindrical or oval knife
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1107Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis for blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1135End-to-side connections, e.g. T- or Y-connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/30Surgical pincettes without pivotal connections
    • A61B2017/306Surgical pincettes without pivotal connections holding by means of suction

Definitions

  • This invention relates to devices for deploying and securing the ends of bypass grafts designed to provide a fluid flow passage between at least two host vessel regions (or other tubular structure regions). More particularly, the invention relates to bypass grafts that are secured at target host vessel locations thereby producing a fluid flow passage from the first host vessel location through the bypass graft and to the second host vessel location.
  • the invention describes sutureless anastomosis systems that do not require cardiopulmonary bypass support when treating coronary artery disease.
  • This invention provides devices and methods to position and secure bypass grafts at host vessel locations without having to stop or re-route blood flow. Accordingly, this invention does not require cardiopulmonary bypass support and arresting the heart while producing anastomoses to the coronary arteries. In addition, this invention mitigates risks associated with suturing, clipping, or stapling the bypass graft to the host vessel(s); namely, bleeding at the attachment sites and collapsing of the vessel around the incision point.
  • the anastomoses of the invention meet the need of being able withstand the pressure exerted by the pumping heart and ensure blood does not leak from the anastomoses into the thoracic cavity, abdominal cavity, or other region exterior to the vessel wall.
  • the invention addresses vascular bypass graft treatment regimens requiring end-side anastomoses to attach bypass grafts to host vessels.
  • the scope of the invention includes improvements to the systems used to position and secure bypass grafts for treating vascular diseases such as atherosclerosis, arteriosclerosis, fistulas, aneurysms, occlusions, thromboses, and the like.
  • the improvements to the bypass grafts and delivery systems of this invention also aid in attaching the ends of ligated vessels, replacing vessels harvested for bypass grafting procedures (e.g. radial artery), and re-establishing blood flow to branching vessels which would otherwise be occluded during surgical grafting procedures (e.g.
  • the invention addresses other applications such as, but not limited to, producing arterial to venous shunts for hemodialysis patients, bypassing lesions and scar tissue located in the fallopian tubes causing infertility, attaching the ureter to the kidneys during transplants, and treating gastrointestinal defects (e.g. occlusions, ulcers, obstructions, etc.).
  • gastrointestinal defects e.g. occlusions, ulcers, obstructions, etc.
  • This invention provides improvements to the sutureless anastomosis systems that enable a physician to quickly and accurately secure a bypass graft to a host vessel or other tubular body structure.
  • the delivery systems of the invention do not require stopping or re-routing blood flow while producing the anastomosis; current techniques require interrupting blood flow to suture, clip, or staple a bypass graft to the host vessel wall.
  • the fittings of the invention are intended to secure biological bypass grafts, obtained by harvesting vessels from the patient or another donor patient, or synthetic bypass graft materials to a patient's host vessel.
  • the fitting embodiments When using harvested vessels, the fitting embodiments must accommodate a variety of harvested vessel sizes and wall thicknesses.
  • the fittings may be incorporated in the bypass graft design to eliminate the step of attaching the bypass graft to the fitting prior to deploying the bypass graft and fitting.
  • One aspect of the invention provides improved fitting embodiments designed to compress into a reduced diameter while attaching the bypass graft to the fitting and/or deploying the fitting through the delivery system. Once deployed, the compressible fittings of the invention expand towards their preformed geometry such that they exert radial force at the vessel attachment sites; this helps maintain the patency of the anastomosis.
  • An aspect of the invention includes angled fittings designed to produce anastomoses between bypass grafts and host vessels such that the angle between the bypass graft and the host vessel reduces turbulent flow near the anastomosis.
  • the angled fittings may also be designed compressible.
  • Sheathless anastomosis embodiments are disclosed which are designed to insert the petals or securing end of the end-side fitting into the host vessel without having to insert the fitting through a deployment sheath.
  • Figures 1A to IF show an end-side fitting capable of being deployed over a guidewire and the deployment steps to position and secure the end-side fitting.
  • Figures 2A to 2C show support device embodiments.
  • Figures 3A and 3B show a slotted support device having a funneled proximal end.
  • Figure 3C shows a reinforcing structure to secure the support device of Figures 3A and 3B.
  • Figure 4 shows a support device having a partially slotted side and a funneled proximal end.
  • Figure 5 shows a curved support device having a funneled proximal end.
  • Figure 6A shows a side view of a dilating end-side fitting.
  • Figure 6B shows a top view of the dilating end-side fitting of Figure 6 A.
  • Figure 6C shows a cross-sectional view of the dilating end-side fitting of Figure 6A taken along the line A-A.
  • Figure 6D shows a top view of a dilating end-side fitting in response to external forces (C).
  • Figure 6E shows a cross-sectional view of the dilating end-side fitting of Figure 6D taken along the line B-B.
  • Figure 7A shows a bottom view of a dilating end-side fitting in a flattened configuration.
  • Figure 7B shows a bottom view of a dilating end-side configured for host vessels having a relatively large diameter compared with the diameter of the bypass graft.
  • Figure 7C shows a top view of a dilating end-side configured for host vessels having a relatively medium or small diameter of the present invention.
  • Figure 7D shows a bottom view of the dilating end-side fitting of Figures 7B or 7C configured for introduction through an opening into a host vessel.
  • Figures 8 A and 8B show a bottom view and a top view of the front piece of a two piece dilating end-side fitting.
  • Figures 8C and 8D show a side view and a top view of the rear piece of a two piece dilating end-side fitting.
  • Figure 9A shows a side view of an introducer configured to advance the petals of a dilating end-side fitting through an opening into a host vessel.
  • Figure 9B shows a bottom view of the introducer of Figure 9A.
  • Figure 9C shows a top view of the introducer of Figure 9 A.
  • Figure 9D shows a bottom view of the introducer of Figure 9 A with the petals of a dilating end-side fitting positioned within the introducer.
  • Figure 9E shows a side view of the introducer of Figure 9A with the petals of a dilating end-side fitting positioned within the introducer.
  • the fittings and deployment systems of the present invention are intended to produce anastomoses between bypass grafts and host vessels to treat vascular abnormalities such as stenoses, thromboses, other occlusions, aneurysms, fistulas, or other indications requiring a bypass graft.
  • the systems of the present invention are also useful in bypassing stented vessels that have restenosed, and saphenous vein bypass grafts that have thrombosed or stenosed.
  • Current approaches for treating stenosed stents have not been successful at safely and reliably removing the lesion and opening the vessel lumen.
  • inventive fitting embodiments discussed herein are directly amenable to robotic surgery and less invasive (i.e. minimally invasive) surgery involving a thoracostomy or mini median stemotomy to access the anastomosis site.
  • the fittings of the present invention enable automation of the attachment of the bypass graft to the fitting, especially when considering the use of the end- side fittings capable of being advanced over a guidewire as described below.
  • the present invention includes end-side fitting embodiments having specific characteristics so that they may be inserted through a small puncture without the need for a deployment sheath.
  • Figures 1 A to IF shows a system for inserting an end-side fitting 2 without requiring the use of a deployment sheath.
  • a guidewire 4 is inserted through the host vessel 6 wall and into the host vessel interior.
  • the end-side fitting has a distal hole or aperture 8 to pass over the guidewire and a proximal hole or aperture 10 that also accepts the guidewire.
  • the distal hole 8 provides a smooth transition from the guidewire 4 to the leading petal 12 of the end-side fitting to readily advance the leading petal through the opening in the host vessel wall.
  • the leading petal 12 has a smooth transition to the base 14 of the end-side fitting to dilate the opening while the end-side fitting is advanced over the guidewire and through the host vessel wall opening.
  • leading petal 12 is an arc having a radius of curvature that approximates the radius of curvature of the host vessel 6.
  • the leading petal 12 may be slightly squeezed together (by hand or using clamps or the like) to produce a better transition from the guidewire to the base 14 of the fitting.
  • the rear petal 16 can be deflected towards the base 14 of the end-side fitting using the guidewire or due to the force exerted by the host vessel wall as the proximal end of the end-side fitting is advanced through the host vessel wall.
  • the rear petal 16 is designed so it is capable of bending towards the base of the fitting but is unable to readily deflect towards the leading petal 12. This anchors the end-side fitting inside the host vessel once the rear petal 16 is advanced through the host vessel wall.
  • the length of the rear petal 16 is less than the diameter of the host vessel and is positioned so the rear petal 1 may be advanced through the opening without the leading petal 12 or base of the fitting having to deform the posterior surface of the host vessel.
  • a support device 18 is used to lock the end-side fitting inside the host vessel 6 and prevent blood leakage between the opening through the host vessel wall and the base 14 of the end-side fitting.
  • Tabs 20 anchor the support device 18 in place, compressing the host vessel wall against the leading petal 12 and rear petal 16 of the end-side fitting.
  • these end-side fittings may be fabricated using any biocompatible material (e.g. nickel titanium, PET,
  • the end-side fittings of the present invention are preferably constructed from a metal (e.g., titanium), alloy (e.g., stainless steel or nickel titanium), thermoplastic (e.g., PTFE), thermoset plastic (e.g., polyethylene terephthalate, or polyester), silicone or combination of the aforementioned materials into a composite structure; other materials may alternatively be used.
  • a metal e.g., titanium
  • alloy e.g., stainless steel or nickel titanium
  • thermoplastic e.g., PTFE
  • thermoset plastic e.g., polyethylene terephthalate, or polyester
  • silicone e.g., polyethylene terephthalate, or polyester
  • end- side fittings fabricated from nickel titanium may be clad with expanded PTFE, polyester, PET, or other material that may have a woven or porous surface.
  • the fittings may be coated with materials such as paralyne or other hydrophilic substrates that are biologically inert and reduce the surface friction.
  • the fittings may be coated with heparin, thromboresistance substances (e.g., glycoprotein Ilb/IIIa inhibitors), antiproliferative substances (e.g., rapamycin), or other coatings designed to prevent thrombosis, hyperplasia, or platelet congregation around the attachment point between the bypass graft and the host vessel.
  • thromboresistance substances e.g., glycoprotein Ilb/IIIa inhibitors
  • antiproliferative substances e.g., rapamycin
  • a material such as platinum, gold, tantalum, tin, tin-indium, zirconium, zirconium alloy, zirconium oxide, zirconium nitrate, phosphatidyl-choline, or other material, may be deposited onto the fitting surface using electroplating, sputtering vacuum evaporation, ion assisted beam deposition, vapor deposition, silver doping, boronation techniques, a salt bath, or other coating process.
  • a still further improvement of the fittings is to include beta or gamma radiation sources on the end-side fittings.
  • a beta or gamma source isotope having an average half-life of approximately 15 days such as Phosphorous 32 or Paladium 103 may be placed on the base and/or petals of the end-side fitting using an ion-implantation process, chemical adhesion process, or other suitable method.
  • the support device 18 is positioned over the base 14 of the fitting and locked in place.
  • the end-side fittings may incorporate tabs 20, threads (not shown), or other locking mechanism with which to secure a support device 18 to the end-side fitting.
  • Tabs 20 are preformed so they protrude radially from the base of the fitting to provide a mechanism to secure the support device, once positioned distal to the tabs.
  • the tabs are also preferably fabricated from a memory elastic material to incorporate a spring characteristic permitting the tabs to be compressed into a reduced diameter during deployment.
  • the tabs do not need to be fabricated from memory elastic materials in the case when they do not need to be compressed into a reduced diameter during introduction.
  • the tabs in the illustrated embodiment are compressed to facilitate inserting the base of the fitting through the delivery system and expand towards their preformed configuration once the fitting is positioned and the external force compressing the tabs is removed.
  • the tabs are fabricated by creating the desired pattern in the fitting material by laser drilling, chemical etching, EDM, or other manufacturing process, whether fitting is fabricated as a sheet or tube.
  • tabs may be fabricated as a separate component and bonded to the fitting by spot welding, laser welding or other suitable manufacturing process.
  • the support device 18 is alternatively locked to the base of the fitting using adhesives, implantable clips, staples, sutures, or other attachment means.
  • the support device of the illustrated embodiment incorporates an outer compliant covering designed to produce a blood-tight seal and prevent damaging the vessel wall by excess compression.
  • the support device also incorporates an encapsulated central memory elastic core used to maintain the position of the support device relative to the vessel wall and prevent permanent deformation of the support device when expanded into an enlarged diameter for positioning around the base of the fitting.
  • the support device is preferably fabricated as a coil with approximately 1 turn. This support device produces a side-opening upon expansion, which permits advancing the support device over the side of the end- side fitting base 14 or the side of the bypass graft 22.
  • the expandable/compressible support device is also capable of producing a secure, blood tight interface between host vessel walls and the petals of end-side fittings having a compressible / expandable base for tailoring the outer diameter of the base to match the size of the bypass graft.
  • the support device may alternatively be constructed from polymers such as polypolyethylene, polycarbonate, PEEK, silicone, nickel titanium, spring stainless steel, other alloy, combination of the aforementioned materials, or other material that may be extruded, injection molded, rolled, or otherwise formed into a tube having the desired cross-sectional profile.
  • the support device may incorporate a braided, woven, or wound layer laminated between two polymer layers to resist kinking and improve the column strength and torque response.
  • the support device may be fabricated with a memory elastic central layer encapsulated with a compliant covering. The support device preferably has porosity sufficient to permit air to diffuse into tissue covered by the support device.
  • the pore size may be as high as approximately 100 ⁇ m as long as the porosity is chosen such that blood does not continually leak through the support device. If the pore size is chosen such that it completely restricts blood flow even when the porosity is extremely high then the pore size needs to be less than approximately 8 ⁇ m.
  • Figures 2A to 2C show additional support device 18 embodiments.
  • the curvature of the support devices shown in Figures 2 A and 2C depends on the radius of curvature for the host vessel. It is prefered that the curvature generally match that of the host vessel to ensure adequate hemostasis at the anastomosis and contact between the support device 18 and the host vessel 6 wall.
  • FIG. 3 A and 3B An alternative support device is shown in Figures 3 A and 3B.
  • This support device 18 has a distal flared end 24 to improve the hemostasis of the end-side fitting, a base that contains notches 26 to accept retaining clips for securing to the fitting base 14, a slot 28 through one side to permit advancing over the side of the fitting base, and a proximal funneled end 30 to improve the compliance and/or blood flow profile transition from the anastomosis to the body of the bypass graft.
  • the retaining clip 32 shown in Figure 3C may be used to secure the support device to the base of the end-side fitting.
  • the distal and proximal rings 34 of the retaining clip 32 fit inside the notches 26 of the support device 18 to prevent axial movement of the retaining clip and support device from the base of the fitting.
  • Figure 4 shows another support device 18 with a distal flared end 24, a slot 28 to permit advancing over the side of the fitting base 14, and a funneled proximal end 30 to transition from the anastomosis to the bypass graft and provide a strain relief to prevent kinking of the bypass graft.
  • Funneled support devices prevent dramatic overexpansion of the bypass graft, improving the transition from the anastomosis to the body of the bypass graft. This transition is particularly important when using harvested vessels such as the saphenous vein as the bypass graft. When exposed to arterial blood pressure, saphenous veins tend to balloon, producing turbulent flow at the anastomosis. This may lead to hyperplasia or other unwanted physiologic abnormalities.
  • Support devices that have a slot 28 to permit advancing over the side of the fitting base or the side 14 of the bypass graft 22 may incorporate a latching mechanism to lock the edges that define the slot 28 together. This eliminates the need to use another locking mechanism such as a retaining clip, suture, implantable clips, staples, or other device.
  • Figure 5 shows an alternative support device 18 that has a curved proximal end 30 to provide a strain relief, produce a smooth transition from the anastomosis to the body of the bypass graft, and direct the blood flow through the bypass graft along a predetermined curve.
  • FIG. 6A to 6E and Figures 7A to 7D show other dilating end-side fittings 2 that meet these requirements.
  • the dilating end-side fittings 2 may incorporate a feature that enables following a guiding mechanism (e.g., guidewire, needle, or small dilator) directing the dilating end-side fitting into the host vessel interior and expand an opening through a host vessel wall.
  • a guiding mechanism e.g., guidewire, needle, or small dilator
  • End-side fitting embodiments may be fabricated from a tube of material having a desired cross-sectional geometry.
  • the desired pattern of petals, tabs, holes, slots, and spaces may be fabricated on the tubular metal material and may be formed using chemical etching, electron discharge machining (EDM), laser cutting, or other manufacturing process.
  • EDM electron discharge machining
  • These end-side fittings may be maintained as a complete tube or may be fabricated to incorporate a gap between opposite sides to make the fitting compressible and expandable, as will be discussed below.
  • the end-side fitting embodiments may be fabricated from a sheet of material cut into the desired pattern and formed (e.g., through an annealing process) into the desired cross-sectional geometry (circular, elliptical, or other shape), as shown in Figures 7 A to 7C.
  • the sides of the fitting may be bonded to form an enclosed tube or may be formed with a gap 36 between opposite sides to enable compressing the fitting into a reduced diameter for positioning the bypass graft over the base of the fitting and inserting the fitting through an opening into a host vessel having a diameter less than the expanded diameter of the fitting.
  • Such compressible fittings also facilitate sizing issues since they accommodate a wide range of bypass graft sizes.
  • the raw material may be fabricated into the desired pattern by chemically etching, EDM, laser cutting, or other manufacturing process.
  • End-side fittings fabricated from sheet stock are then wrapped around mandrels having the desired resting cross-sectional profile(s) and the end-side fitting is heated until it assumes this configuration. If the sides are to be bonded, spot welding, laser welding, or other manufacturing process may be employed.
  • Figures 6A to 6E show a dilating end-side fitting that, like the fitting of Figures 2A-2F, does not require the use of a deployment sheath for insertion into a host vessel 6.
  • a guidewire may be inserted through the host vessel wall and into the host vessel interior, and the end-side fitting may or may not be capable of advancing over a guidewire (not shown).
  • the leading petal 12 of the fitting provides a smooth transition from the opening into the host vessel along the leading petal of the end-side fitting to readily advance the leading petal 12 through the opening in the host vessel wall.
  • the leading petal 12 has a smooth transition to the base 14 of the end-side fitting 2 to dilate the opening while the end-side fitting is advanced through the host vessel wall opening.
  • the leading petal 12 also incorporates links 38 that define spaces 40 throughout the leading petal 12.
  • the spaces 40 minimize the amount of foreign material exposed to blood flow and the links 38 permit compressing the leading petal into a reduced cross-section for insertion through an opening through the host vessel wall.
  • the cross-section of the leading petal 12 (shown in Figure 6C) is an arc having a radius of curvature to approximate the radius of curvature of the host vessel in the fittings resting configuration.
  • the leading petal 12 may be slightly compressed together (by hand or using clamps) as shown in Figures 6D and 6E to produce a better transition for insertion through an opening in the host vessel wall; this also improves the transition from the leading petal to the base of the fitting and prevents scraping the side of the host vessel wall during insertion (especially when inserting the end-side fitting into a host vessel having a small or medium size diameter.
  • the rear petal 16 may be deflected towards the base 14 of the end-side fitting using the guidewire, clamp, or due to the force exerted by the host vessel wall as the proximal end of the end-side fitting is advanced through the host vessel wall.
  • This rear petal is designed so it is capable of bending towards the base of the fitting but is unable to readily deflect towards the leading petal 12.
  • the rear petal may be fabricated such that it readily deflects forward toward the leading petal. This is especially useful when a guidewire may be used to compress the rear petal toward the leading petal while inserting the end-side fitting through an opening into the host vessel wall, as previously discussed.
  • the rear petal 16 further anchors the end-side fitting inside the host vessel.
  • the length of the rear petal 16 is less than the diameter of the host vessel and is positioned so the rear petal 16 may be advanced through the opening without the leading petal 12 or base of the fitting having to deform the posterior surface of the host vessel.
  • a support device is used to lock the end-side fitting inside the host vessel and prevent blood leakage between the opening through the host vessel wall and the base 14 of the end-side fitting.
  • the rear petal 16 may be fabricated as a separate component from the fitting, as shown in Figures
  • This separate rear petal member 42 is capable of locking to the distal leading component after the fitting is positioned through an opening in the host vessel wall and the rear petal is positioned appropriately.
  • the stem or base 14 of the fitting incorporates at least one slot 44 for the rear petal member 42 to slide into.
  • the end-side fitting also incorporates a leading petal 12, side petals 46 that may or may not compress during insertion, holes 40 through the leading and side petals, relief cuts 48 defining extensions 50 that enhance hemostasis at the anastomosis, and a base or stem 14 for securing the bypass graft and maintaining the patency of the opening through the host vessel wall.
  • the rear petal is advanced through the slot 44 in the base or stem 14 of the fitting and is secured to the base or stem of the fitting using a locking mechanism 52.
  • the rear petal may also include holes to improve flexibility of the petal and promote cellular growth.
  • an oval hole 40 in the leading petal 12 is adapted to follow a guidewire 4 previously inserted through the host vessel wall and into the lumen, as shown in Figure 7D.
  • the guidewire 4 (or other mechanism as previously described), inserted through the host vessel wall, is inserted through the oval hole 40 such that when the end-side fitting is angled, the distal tip of the leading petal 12 follows the surface of the guidewire.
  • the side petals 46 are maintained in a compressed configuration for the expansion of the opening and deployment through the host vessel wall.
  • a guidewire 4 may be inserted through at least one of the spaces 40 incorporated in the side petals 46 and/or rear petal 16 such that compressing the petals inward using the guidewire holds the side petals 46 and the rear petal 16 in a compressed configuration.
  • the guidewire 4 further extends through the oval hole 40 in the leading petal 12, as discussed above.
  • the compressed orientation of the side petals 46 and rear petal 16 enables dilating the opening through the host vessel wall facilitating advancement of the petals of the end-side fitting into the host vessel interior.
  • the mechanism used to maintain the side petals 46 and/or rear petal(s) 16 in a compressed configuration is removed enabling the petals of the fitting to expand towards their preformed configuration.
  • the petals engage the interior surface of the host vessel.
  • a support device previously discussed, is advanced over the stem or base 14 of the end-side fitting and is secured to maintain the position of the end-side fitting and prevent blood leakage.
  • relief cuts 48 may be incorporated in the end-side fitting to define extensions 50 which minimizes blood leakage and enable configuring the radius of curvature of the petals to maintain the maximum strain during compressing below the 8 percent limit characteristic of memory elastic materials.
  • a thin wall sheath 54 having a height substantially smaller than the width or length may be used to maintain the side petals 46 and rear petal 16 in a compressed orientation during insertion through an opening into the host vessel 6.
  • a remote extension 56 is attached to a handle (not shown) and permits remote manipulation of the thin wall sheath 54.
  • the interior surface of the thin wall sheath 54 matches the shape of the distal end of the compressed end-side fitting and provides an opening for the base or stem 14 of the fitting to emerge.
  • the thin wall sheath resembles a dilator in that it provides a smooth surface and transition to expand the opening into the host vessel.
  • the thin wall sheath provides at least one slot 58 on the top 60 of the sheath and at least one slot 62 on the bottom 64 of the sheath which permit separation of the thin wall sheath, once deployed, so the thin wall sheath 54 may be removed from around the compressed end-side fitting.
  • the thin wall sheath 54 also has a minimal wall thickness to facilitate separation of the distal end of the thin wall sheath along the top slots 58 and bottom slots 62. Also, other mechanisms may be used for splittable sheaths that hold the sheath in an intact configuration yet permit separation along the at least one side may be incorporated in top and bottom slots of this thin wall sheath 54 to enable remote separation of the thin wall sheath from around the end-side fitting. Removal of the thin wall sheath 54 allows the side petals 46 and the rear petal 16 to return towards their resting configuration such that the side petals 46 and rear petal 16 engage the interior surface and secure the end-side fitting 2 (thus the attached bypass graft 22) to the host vessel 6.
  • the petals in many of these fitting embodiments are shown straight (i.e. at an angle of approximately zero degrees from the base of the fitting).
  • the petals may be thermally formed at any angle between about 30 degrees and about 150 degrees from the base of the fitting such that the petals contact the interior surface of the host vessel once the fitting is inserted through the host vessel wall.
  • the petals, having an angle between about 30 degrees and about 150 degrees from the base of the fitting in their resting orientation, also compress into a reduced outer diameter during deployment through delivery system and expand towards their resting configuration once deployed inside the host vessel.
  • the number of petals incorporated in the end-side fitting design depends on the size of the bypass graft and the size of the host vessel.
  • the number of petals also depends on the desired tensile strength between the fitting and the host vessel; increasing the number of petals in turn increases the force required to pull the fitting petals out of the host vessel.
EP00992636A 1999-12-06 2000-12-05 Terminolaterale anastomosesysteme Withdrawn EP1235521A2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16910499P 1999-12-06 1999-12-06
US169104P 1999-12-06
US17882200P 2000-01-28 2000-01-28
US178822P 2000-01-28
PCT/US2000/042569 WO2001041653A2 (en) 1999-12-06 2000-12-05 End-side anastomosis systems

Publications (1)

Publication Number Publication Date
EP1235521A2 true EP1235521A2 (de) 2002-09-04

Family

ID=26864770

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00992636A Withdrawn EP1235521A2 (de) 1999-12-06 2000-12-05 Terminolaterale anastomosesysteme

Country Status (2)

Country Link
EP (1) EP1235521A2 (de)
WO (1) WO2001041653A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998019625A2 (en) * 1996-11-08 1998-05-14 Houser Russell A Percutaneous bypass graft and securing system
US20020173809A1 (en) * 1999-09-01 2002-11-21 Fleischman Sidney D. Sutureless anastomosis system deployment concepts
US6702828B2 (en) 1999-09-01 2004-03-09 Converge Medical, Inc. Anastomosis system
CA2424029C (en) 2000-09-29 2008-01-29 Cordis Corporation Coated medical devices
US7182771B1 (en) 2001-12-20 2007-02-27 Russell A. Houser Vascular couplers, techniques, methods, and accessories
US7591827B2 (en) 2002-11-19 2009-09-22 J. Donald Hill Conduit coupling devices and methods for employing such devices
EP1562491B1 (de) 2002-11-19 2010-09-22 J. Donald Hill System und vorrichtung zum durchführen von minimal invasiver koronarer arterienbypassimplantation
US20130197546A1 (en) 2007-08-02 2013-08-01 Bioconnect Systems, Inc. Implantable flow connector
WO2009018583A1 (en) 2007-08-02 2009-02-05 Bio Connect Systems Implantable flow connector
US10434293B2 (en) 2012-04-15 2019-10-08 Tva Medical, Inc. Implantable flow connector
US9314600B2 (en) 2012-04-15 2016-04-19 Bioconnect Systems, Inc. Delivery system for implantable flow connector

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ289275B6 (cs) * 1996-08-21 2001-12-12 Milan Mudr. Csc. Krajíček Vloľka anastomózy v cévním systému
US7708769B1 (en) * 1997-03-13 2010-05-04 United States Surgical Corporation Graft attachment assembly
US6056762A (en) * 1997-05-22 2000-05-02 Kensey Nash Corporation Anastomosis system and method of use
EP0894475A1 (de) * 1997-07-31 1999-02-03 Medtronic, Inc. Vorrichtung zum zeitweiligen Abdichten von Blutgefässen bei Anastomose
NO981277D0 (no) * 1998-03-20 1998-03-20 Erik Fosse Metode og anordning for suturfri anastomose

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0141653A3 *

Also Published As

Publication number Publication date
WO2001041653A3 (en) 2002-02-21
WO2001041653A2 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
US6648900B2 (en) Anastomosis systems
US6702828B2 (en) Anastomosis system
US20020173809A1 (en) Sutureless anastomosis system deployment concepts
US6494889B1 (en) Additional sutureless anastomosis embodiments
US6972023B2 (en) Distal anastomosis system
EP1267748B1 (de) Stent mit hüllenbefestigungen
US6699277B1 (en) Stent with cover connectors
EP1257234B1 (de) Endoluminales transplantat-system mit verzweigtem endoluminalen transplantat
US7182771B1 (en) Vascular couplers, techniques, methods, and accessories
US20030023252A1 (en) Distal anastomosis system
US20030009183A1 (en) Distal anastomosis system
EP1263348A2 (de) Intraluminale prothese
US20040068278A1 (en) Anastomosis systems
EP1235521A2 (de) Terminolaterale anastomosesysteme
US20040097993A1 (en) Advanced anastomosis systems
EP3991698B1 (de) Medizinische implantate zur verbesserung der heilungsreaktion und der effektiven langlebigkeit von blutgefässen und anastomosen
EP3763327A1 (de) Aortenbehandlungsvorrichtung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020607

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060701